CPRT Deep Analysis

What Is Mr. Market Pricing In?

At $33.39 per share with 967 million shares outstanding, the market values Copart at $32.3 billion — approximately 26.3x trailing net income of $1.23 billion in FCF and 20.9x trailing EPS of $1.60. The market's core thesis can be stated precisely: Copart is a wonderful business that is approximately fairly valued — the market is willing to pay a quality premium for fifteen consecutive years of earnings growth and a wide duopoly moat, but is not willing to pay a growth premium because the current insurance volume decline (U.S. units down 10.7%) signals that the historical 12-15% revenue CAGR...

Read Full Market Thesis Analysis

What Mr. Market is pricing in, implied growth assumptions, and consensus vs. reality

Executive Summary

ROIC (TTM)

16.21%

vs WACC ~7%

FCF Per Share

$1.27

vs EPS $1.58

FCF Yield

4%

$1.27 / $33.39

Operating Margin

36.5%

TTM

THE BET

Copart's buyer liquidity flywheel — where more bidders drive higher auction prices, attracting more insurance consignors — creates toll-bridge economics at 36.5% operating margins with zero debt. At 14.2x operating EV/EBITDA, Mr. Market prices in permanent growth deceleration from a cyclical insurance volume trough that CEO Liaw calls 'more cyclical than secular.'

THE RISK

Insurance volume decline deepens beyond cyclical correction (U.S. units -10.7% last quarter). Operating margins continue compressing from 42% toward 30% as investment spend outpaces revenue growth. Total-loss frequency tailwind decelerates as rate approaches mathematical ceiling near 30%. IAA/RB Global narrows buyer liquidity gap with technology investment. Management capital allocation remains passive — $5.1B cash pile earning treasury yields while share count drifted up 3.6%.

WHAT BREAKS IT

U.S. insurance unit volumes decline >12% for 3+ consecutive quarters, signaling structural coverage loss not cyclical softness (current: -10.7%) — Stock at risk
Operating margin falls below 30% for 2+ quarters as investment spend fails to produce revenue acceleration (current: 36.5%) — Thesis killer
IAA/RB Global closes ASP gap to within 3% of Copart pricing, undermining the liquidity premium that locks in insurance contracts (current: ~10%+ ASP advantage) — Thesis killer
Total-loss frequency plateaus or reverses below 22% due to ADAS/vehicle safety improvements (current: 24.2%) — Thesis killer
Share buybacks stall while share count continues rising above 975M diluted (current: 967M, $500M YTD repurchases) — Stock at risk

Legendary Investors Analysis

View Full Debate

SIMULATED

Source: Council analysis from CPRT Deep Research. Simulated investor perspectives based on their known investment frameworks, applied to verified financial data.

MAJORITY OPINION: Buy Lower

6 of 7 council members

Copart operates one of the most compelling near-toll-booth franchises in industrial services — a duopoly (with IAA/RB Global) in salvage vehicle auctions that insurance companies cannot economically bypass. When an insurer declares a vehicle a total loss, the salvage process must flow through an auction platform with the buyer network, land infrastructure, and technology to maximize recovery values. Using split-adjusted EPS from ROIC.ai — $0.99 (FY21), $1.15 (FY22), $1.30 (FY23), $1.42 (FY24) — and normalizing at approximately $1.29 mid-cycle, the stock trades at roughly 26x normalized earnings. This is not cheap for a business currently reporting a -3.6% revenue decline and -8% unit volumes, but it is reasonable for a franchise with 35-40% operating margins and durable competitive positioning. The majority views the current unit decline as cyclical rather than structural, driven by consumer pullback on collision coverage, softer claims activity, and elevated repair-vs-total thresholds — all forces that have historically mean-reverted with insurance pricing cycles.

However, the timing and pace of recovery remain uncertain, and leading indicators like policies-in-force and collision coverage attachment rates have not yet inflected. With the stock trading near our estimated fair value of $35-38 per share, we see no urgency to establish positions today. We would prefer to accumulate shares at $29-31, which provides a 15-20% margin of safety and better compensates for near-term earnings uncertainty. Capital allocation is adequate but not exceptional at this stage. Management has repurchased approximately $500M in shares year-to-date (~15 million shares at ~$33), representing roughly 1.5% of shares outstanding.

However, the share count rose from 933 million in FY20 to 961 million in FY24, indicating that stock-based compensation has historically offset buybacks. Net accretion may be closer to 0.5-1.0% annually once SBC dilution is netted — meaningful over time but not a primary return driver. The company's strong balance sheet (approximately $2.0-2.5 billion in net cash after reconciling balance sheet figures) provides both downside protection and optionality for opportunistic capital deployment. On a blended valuation — averaging P/E ($1.29 × 27x = $34.83), FCF yield ($0.99 FCF/share at a 2.8% yield = $35.36), and EV/EBIT (~$1.6B operating income at 22x less net cash = $34.33) — fair value centers around $35-37 per share, with upside to $38-40 if unit volumes recover to trend growth within 18 months. At $33.39, the risk/reward is modestly favorable but does not offer the margin of safety we require for a full position. We recommend beginning to accumulate below $30 and building conviction as insurance volume data inflects.

Buffett: Buy Lower ($30) Munger: Buy Lower ($29) Tepper: Buy Now ($33.39) Vinall: Buy Lower ($30) Pabrai: Buy Now ($33.39)

MINORITY OPINION: Avoid Stock

1 of 7 council members

The minority sees Copart at $33.39 as a compelling asymmetric opportunity in a dominant franchise experiencing temporary cyclical headwinds. Insurance volume cycles have always mean-reverted — the question is timing, not direction. With the stock trading at roughly 23x TTM earnings of $1.42 for a business with 35-40% operating margins, a near-monopoly position in salvage auctions, and ~$2B in net cash, the downside is well-protected while the upside from volume normalization could drive 20-30% returns within 18 months.

Waiting for $29-30 risks missing the recovery entirely, as insurance volume data tends to inflect quickly once carrier pricing cycles complete. David Tepper sees classic catalyst-driven asymmetry: downside to ~$27-28 (a further 15-17% decline requiring sustained volume deterioration and multiple compression) versus upside to $40-42 (volume recovery driving EPS to $1.55+ at 26-27x). That's roughly 2:1 reward-to-risk, which is actionable. Mohnish Pabrai frames it as a quintessential 'heads I win, tails I don't lose much' situation — the company's land portfolio alone (which Copart owns rather than leases) provides a significant asset floor, while the duopoly market structure ensures Copart will participate fully in any volume recovery. Both minority members acknowledge the SBC dilution concern and the uncertainty around volume recovery timing, but argue that these are well-understood risks already reflected in the multiple compression from historical averages of 30-35x to the current 23-26x range. The market is giving you a quality compounder at a cyclical trough multiple — that's precisely when patient capital should be deployed.

Kantesaria: Avoid Stock

🧓

Warren Buffett

Berkshire Hathaway • Oracle of Omaha

MAJORITY

Verdict

BUY LOWER ($30)

Investment Framework Applied (Source: Council Opinions)

Investment framework analysis based on Warren Buffett's known principles applied to CPRT.

Conviction Level: 7/10
Fair Value: $37 — derived from three approaches: (1) Normalized EPS of $1.29 × 27x quality multiple = $34.83; (2) TTM FCF of ~$962M / 967M shares = $0.99/share, adjusted for elevated capex to ~$1.10 owner earnings × 32x = $35.20; (3) Through-cycle EPS recovery to $1.50 within 24 months × 25x = $37.50. Weighted average: ~$36-37, rounded to $37 to reflect recovery optionality in a business I understand very well.
Buy Below: $30 — based on 23x normalized EPS of $1.29 (three-year average of split-adjusted ROIC.ai figures: $1.15, $1.30, $1.42), which provides approximately 19% margin of safety below my blended fair value estimate and compensates for the 2-3 quarter uncertainty in insurance volume recovery.

Key Points (from Source)

Copart operates a simple, understandable business within a structural duopoly that I find very attractive. When an insurance company totals a vehicle, the salvage must be auctioned — and the realistic choices are Copart or IAA. This is not unlike a toll bridge: the activity cannot economically occur without paying one of two operators. With approximately 60% US market share and a buyer network spanning 190+ countries, Copart's competitive position is deeply entrenched and self-reinforcing.
The current unit volume decline of -8% and revenue contraction of -3.6% concern me not because they threaten the franchise, but because they create uncertainty around the timing of normalization. Management attributes the softness to consumer pullback on collision coverage and softer claims activity — forces I agree are more cyclical than secular. However, I have no ability to predict when insurance volumes will inflect, and I want to be compensated for that uncertainty with a meaningful discount to intrinsic value.
Capital allocation is adequate but I would like to see management demonstrate sustained net share reduction. The share count increased from 933 million in FY20 to 961 million by FY24, suggesting stock-based compensation has historically outpaced buybacks. The recent $500M buyback commitment is encouraging, but until net dilution reverses convincingly, I will not credit significant per-share accretion in my valuation. The $2B+ cash position provides excellent downside protection and strategic flexibility.

Verdict & Actions

Disagreements: I respectfully disagree with David Tepper's urgency to buy at current prices. While the 2:1 risk/reward arithmetic is seductive, it assumes a volume recovery within his typical 12-18 month catalyst window. Insurance behavioral shifts — consumers dropping collision coverage — can persist for multiple years, particularly if cost-of-living pressures remain elevated. I prefer to let time and price align rather than front-run a catalyst with uncertain timing.

Actions:

Begin accumulating shares below $30 in measured increments, targeting a 3-4% portfolio position over 6-12 months as insurance volume data provides confirmation of cyclical trough.
Monitor quarterly unit volume trends and collision coverage attachment rates as leading indicators. If units inflect positive for two consecutive quarters, consider accelerating purchases up to $33.

👴

Charlie Munger

Vice Chairman, Berkshire Hathaway (1924-2023)

MAJORITY

Verdict

BUY LOWER ($29)

Investment Framework Applied (Source: Council Opinions)

Investment framework analysis based on Charlie Munger's known principles applied to CPRT.

Conviction Level: 7/10
Fair Value: $36 — I approach this by asking what a rational buyer would pay for the entire business. Operating income of approximately $1.6B on a capital-light (relative to returns) platform, growing at 8-12% through cycles. At 22x operating earnings: $35.2B enterprise value. Subtracting approximately $2B in net cash yields ~$33.2B equity value or $34.33 per share on current earnings. Adding a modest premium for recovery optionality and compounding brings fair value to $36.
Buy Below: $29 — applying approximately 20% margin of safety to my fair value estimate of $36. I demand a wider margin because the inversion exercise reveals several scenarios where this business could underperform expectations for longer than the market anticipates.

Key Points (from Source)

Inverting the question — 'What could kill Copart?' — reveals a business with exceptional durability. Insurance companies cannot economically build in-house auction platforms (they lack the buyer network, land infrastructure, and technology). New entrants face massive barriers: Copart owns its land rather than leasing, has spent decades building a global buyer base, and benefits from powerful network effects where more buyers attract more sellers. The duopoly structure has been stable for over two decades, which tells me something important about the competitive dynamics.
Management quality passes my integrity test but not my capital allocation excellence test — yet. The decision to own rather than lease land is shrewd and creates a durable competitive advantage. However, the rising share count (933M to 961M over four years) while simultaneously running buyback programs reveals that management is, to some extent, running in place on per-share value creation. I want to see the announced buyback acceleration produce genuine net share reduction over the next 4-6 quarters before giving full credit.
The insurance volume cyclicality is a feature, not a bug — it creates periodic opportunities to buy a wonderful business at a merely good price. Current conditions (units -8%, revenue -3.6%) represent exactly this type of opportunity, but I insist on adequate compensation. At $33.39, the stock offers perhaps 8-10% upside to fair value, which is insufficient margin of safety for a business in a cyclical trough with uncertain recovery timing.

Verdict & Actions

Disagreements: I push back on Mohnish Pabrai's characterization of the land portfolio as providing a meaningful 'asset floor.' While Copart's owned real estate is valuable, salvage yard land in suburban/exurban locations is a specialized asset class with limited alternative uses and potentially significant environmental liabilities. The operating franchise value — not the land — is what protects the downside, and that franchise is temporarily impaired by volume headwinds.

Actions:

Set limit orders at $29 and be patient. This business has given patient investors multiple opportunities to buy at attractive prices over the past decade, and current conditions suggest another entry point below $30 is plausible within 6-12 months if volume headwinds persist.
Track share count quarterly — if management achieves net share reduction (after SBC) for two consecutive quarters while maintaining the buyback pace, increase conviction and consider buying at prices up to $31.

📊

Dev Kantesaria

Valley Forge Capital • Quality Compounder Investor

MINORITY

Verdict

AVOID STOCK

Investment Framework Applied (Source: Council Opinions)

Investment framework analysis based on Dev Kantesaria's known principles applied to CPRT.

Conviction Level: 9/10

Key Points (from Source)

[Philosophy Guardrail] This is a commodity/cyclical business that fails my toll booth inevitability test. Alternative suppliers exist — customers can source from dozens of global competitors. I categorically exclude commodity cyclicals regardless of balance sheet strength or cycle timing.
Copart passes my toll booth test with high marks. When an insurance company declares a vehicle a total loss — a mandatory, non-discretionary event driven by actuarial math — the salvage must flow through an auction platform. The critical question is: can this activity occur without paying Copart's toll? The answer is 'only by paying IAA's toll instead,' which means the economic activity is trapped within a two-player system. This is structurally similar to Visa/Mastercard in payments — the customers have a choice of two, but they must choose one. I find this level of inevitability compelling.
My concern centers on capital allocation discipline, particularly the FCF-after-SBC metric I prioritize. With TTM FCF of ~$962M but stock-based compensation running at levels that produced net dilution of approximately 28 million shares over four years (933M to 961M), the true owner FCF is lower than the headline suggests. Management must demonstrate that buybacks are producing genuine per-share compounding, not merely offsetting employee compensation. I want to see FCF after SBC growing at 8%+ before assigning a full compounding machine premium.
The current valuation is reasonable but not compelling for a new position. At 2.96% FCF yield versus a 4.3% risk-free rate, I need to believe in sustained double-digit FCF growth to justify the current price — and that growth is temporarily challenged by the insurance volume cycle. I would prefer to initiate at a price where the starting FCF yield is closer to 3.5%, which implies approximately $31 per share on current FCF, giving me a comfortable margin while the volume cycle works itself out.

Verdict & Actions

Disagreements: I disagree with David Tepper's catalyst-driven framing. My framework does not depend on correctly timing cyclical inflections — I invest in structural inevitability and let the compounding do the work. If the volume recovery takes 24 months instead of 12, Tepper's asymmetric trade becomes much less compelling, whereas my approach simply requires buying at a price where the starting yield provides adequate return even without a near-term catalyst.

Actions:

Begin accumulating below $31, targeting a 2-3% portfolio weighting initially. Increase to 4-5% if management demonstrates net share reduction for three consecutive quarters while maintaining FCF margins above 25%.
Monitor FCF-after-SBC as the primary capital allocation metric. If this figure shows 10%+ annual growth, increase conviction that this is a genuine compounding machine rather than a business diluting shareholders through equity compensation.

📈

David Tepper

Appaloosa Management • Distressed & Macro Investor

MINORITY

Verdict

BUY NOW ($33.39)

Investment Framework Applied (Source: Council Opinions)

Investment framework analysis based on David Tepper's known principles applied to CPRT.

Conviction Level: 7/10
Fair Value: $40 — Catalyst-driven: If insurance volumes recover 5-8% and revenue returns to mid-single-digit growth (consistent with 10-year historical averages), EPS should reach $1.55-$1.60 within 18 months. At a normalized 26x multiple for a dominant franchise exiting a cyclical trough: $1.57 × 26x = $40.82. Cross-checking with FCF: recovery-scenario FCF/share of $1.15 at a 2.8% yield = $41.07. Downside case: extended volume weakness compresses EPS to $1.20 at 22x = $26.40, implying ~$27 floor. Risk/reward: ~$7 upside versus ~$6 downside, roughly 1.2:1 on point estimate, improving to ~2:1 if you weight recovery probability at 60%+.
Buy Below: $33.39 — current price, begin building position immediately. Add aggressively on any pullback below $30.

Key Points (from Source)

This is a textbook asymmetric setup in a franchise business. Copart trades at 23x TTM earnings — well below its 10-year average of 30-35x — because the market is extrapolating a temporary insurance volume decline into the valuation. The -8% unit decline and -3.6% revenue contraction are real, but they stem from consumer decisions about insurance coverage that are historically cyclical, not structural shifts in the salvage auction business model. When fear creates a discount in a duopoly, I pay attention.
The catalyst path is clear even if the timing is uncertain. Insurance carriers are completing multi-year rate increase cycles. As rates stabilize and competition for policies resumes, carriers will lower deductibles and consumers will restore collision coverage — the economics of going uninsured or underinsured on a depreciating asset only work for so long. Miles driven data remains robust. The used vehicle market remains active. The structural demand for salvage auctions is intact; what's compressed is the flow-through of insured total-loss claims.
The balance sheet makes this a low-risk bet. Approximately $2 billion in net cash on a $32B market cap means the equity is partially de-risked by financial assets. Even in a bear case where volumes decline another 5-10% from here, Copart generates enough free cash flow (~$800M+) to cover all operations and continue buying back stock. The floor is well-established, and I'm getting paid to wait for recovery through buyback accretion and cash accumulation.

Verdict & Actions

Disagreements: I challenge Warren Buffett and Charlie Munger's insistence on waiting for $29-30. In my experience, by the time insurance volume data confirms a trough, the stock is already 15-20% higher. These tightly held duopolies re-rate quickly on the first positive data point. The opportunity cost of sitting on the sidelines — missing the initial 15-20% move while waiting for confirmation — is real and underappreciated by value investors who focus exclusively on entry price rather than expected value.

Actions:

Initiate a 3-4% position at current prices ($33-34). Add up to 6% total if shares trade below $30 on continued volume weakness, which would represent a genuinely compelling entry point.
Set a 12-18 month review window. If unit volumes have not stabilized or shown sequential improvement by Q4 FY26 (approximately 9-12 months from now), re-evaluate the cyclical thesis and consider whether structural headwinds (ADAS, autonomous vehicles) are accelerating.

📝

Robert Vinall

RV Capital • Long-Term Compounder

MAJORITY

Verdict

BUY LOWER ($30)

Investment Framework Applied (Source: Council Opinions)

Investment framework analysis based on Robert Vinall's known principles applied to CPRT.

Conviction Level: 7/10
Fair Value: $37 — Using a reinvestment framework: Copart earns ROIC of approximately 16% (ROIC.ai TTM) on reported invested capital, with the potential to approach 20%+ as elevated capex normalizes. If the business reinvests 60% of earnings at 16-18% ROIC, intrinsic value compounds at approximately 10-11% annually. Starting from current normalized EPS of $1.29, five-year forward EPS reaches approximately $2.08 at 10% CAGR. Discounted at 10% with a 25x terminal multiple: $2.08 × 25 / 1.10^5 = $32.30, plus interim retained cash value of approximately $5/share = $37.30. Rounded to $37.
Buy Below: $30 — representing approximately 19% margin of safety below fair value of $37 and a price where the compounding mathematics become highly attractive even under conservative reinvestment assumptions.

Key Points (from Source)

Copart's reinvestment runway is the most underappreciated aspect of this business. The company is in the middle innings of a global expansion — salvage auction markets in continental Europe, the Middle East, and Asia are fragmented and underdeveloped compared to the US. Each new market requires upfront investment in land, technology, and buyer network development, but the long-term returns on these investments should approach or exceed US-level ROIC as the platforms mature and achieve scale. This is a genuine multi-decade compounding opportunity.
The company's decision to own rather than lease land is strategically brilliant from a reinvestment perspective. While it depresses near-term FCF (capex is elevated), it creates a permanent competitive advantage — new entrants cannot simply lease their way into the business because the land required for salvage operations is increasingly scarce near urban centers. Copart is essentially building a land bank that appreciates while generating high-return operating income. The elevated capex is an investment, not a cost, and should normalize as the current build cycle completes.
The ROIC of 16.21% (TTM) is solid but understates the economics of the core business because it includes the drag from the heavy land investment cycle and the cash drag from the $2B+ cash position sitting on the balance sheet. Adjusting for excess cash and normalizing capex, the core business ROIC is likely in the 20-25% range, which places Copart among the highest-quality reinvestment opportunities in public markets.

Verdict & Actions

Disagreements: I push back on Dev Kantesaria's emphasis on FCF-after-SBC as the primary metric. While I agree SBC dilution is a concern, Copart's SBC is modest relative to technology companies and serves a legitimate purpose in retaining operational talent across a geographically dispersed land-based business. The incremental dilution of approximately 0.7% per year (before buybacks) is manageable and should not be the primary lens through which we evaluate a business with 10%+ earnings growth potential.

Actions:

Accumulate below $30, building toward a 4-5% portfolio position over 6-12 months. Focus on the capex normalization timeline as the key variable — when annual land acquisition spending moderates, FCF conversion should improve materially.
Track international segment revenue growth and margin trajectory quarterly. If international ROIC approaches 12%+ within 3 years, this validates the reinvestment thesis and justifies upgrading conviction to 8-9.

🎯

Mohnish Pabrai

Pabrai Investment Funds • Dhandho Investor

MINORITY

Verdict

BUY NOW ($33.39)

Investment Framework Applied (Source: Council Opinions)

Investment framework analysis based on Mohnish Pabrai's known principles applied to CPRT.

Conviction Level: 7/10
Fair Value: $38 — Simple framework: Heads scenario (60% probability): Insurance volumes recover within 18 months, EPS reaches $1.55, stock re-rates to 27x historical average = $41.85. Tails scenario (40% probability): Volume weakness persists, EPS flat at $1.42, multiple compresses to 21x = $29.82. Probability-weighted expected value: (0.60 × $41.85) + (0.40 × $29.82) = $25.11 + $11.93 = $37.04. Rounded to $38 to account for balance sheet optionality (net cash provides additional value not captured in earnings multiples).
Buy Below: $33.39 — current price offers favorable 'heads I win, tails I don't lose much' dynamics. The downside is well-protected by asset values and duopoly economics, while the upside from cyclical recovery is substantial.

Key Points (from Source)

This is a classic Pabrai setup — a high-quality business facing a temporary, well-understood cyclical headwind that the market is pricing as if it might be permanent. Insurance volume cycles have a 100% historical reversion rate. Consumers who drop collision coverage or raise deductibles eventually reverse those decisions — often prompted by a single accident scare, a vehicle loan requirement, or simply the return of affordability as insurance rates stabilize. The question is when, not if, and at 23x TTM earnings, the market is paying me to be patient.
The 'tails I don't lose much' side of the equation is compelling. Copart owns its land (a scarce, appreciating asset), operates in a structural duopoly with 35-40% operating margins, generates approximately $960M in annual free cash flow even in a down cycle, and holds roughly $2B in net cash. In a severe downside scenario — say units decline another 10% and margins compress 300 basis points — FCF might drop to $700-750M, but the business remains solidly profitable and the balance sheet absorbs the stress with ease. The floor is approximately $27-28 per share, representing roughly 15-17% downside from here.
I am cloning the conviction of fundamental franchise analysis here. Copart's competitive position has strengthened through every cycle over the past 20 years. Market share has grown, international presence has expanded, and the technology platform has widened the gap versus IAA. Cyclical weakness in a franchise that gets structurally stronger through cycles is exactly the temporary problem I look for — it's the kind of situation where doing nothing (holding through the trough) generates excellent long-term returns.

Verdict & Actions

Disagreements: I respectfully challenge Charlie Munger's skepticism about the land portfolio as a downside protector. While salvage yards are specialized assets, Copart's locations near major metropolitan areas have substantial alternative-use value for logistics, last-mile delivery, and industrial purposes. The land portfolio alone is likely worth $8-10 billion at replacement cost — roughly 25-30% of the current market cap. This is not a theoretical floor; it represents real, tangible asset value that limits permanent capital loss.

Actions:

Initiate a 4-5% portfolio position at current prices. This is a business I would be comfortable owning for 10+ years through any cycle, and the current price offers reasonable entry into a franchise that rarely trades at a cyclical-trough multiple.
If shares decline to $28-29 on continued volume weakness, increase position to 7-8% — at that level, the risk/reward becomes exceptional and the margin of safety approaches deep-value territory for a franchise-quality business.

🌱

Pulak Prasad

Nalanda Capital • Evolutionary Survival Investor

MAJORITY

Verdict

BUY LOWER ($28)

Investment Framework Applied (Source: Council Opinions)

Investment framework analysis based on Pulak Prasad's known principles applied to CPRT.

Conviction Level: 7/10
Fair Value: $35 — Using through-cycle conservative earnings: Normalized EPS of $1.25 (slightly below mid-cycle to account for the uncertainty in volume recovery timing) × 28x for a Darwinian survivor with proven cycle resilience = $35.00. Cross-checking: Through-cycle FCF/share of approximately $0.95 × 37x (reflecting long-term compounding premium minus cyclical discount) = $35.15. Both approaches converge at $35.
Buy Below: $28 — I demand the widest margin of safety on the council because my evolutionary framework requires that I account for long-tail risks that other members may underweight. At $28, I am paying approximately 22x depressed earnings for a business with Darwinian survivorship characteristics, which provides adequate compensation for fat-tail risks including ADAS-driven accident reduction and potential regulatory shifts.

Key Points (from Source)

Copart exhibits the hallmarks of a Darwinian survivor — a business that has not merely endured competition and cycles but has emerged stronger from every challenge. Over the past two decades, the company has survived the transition from physical to online auctions (which it led), weathered the 2008-09 financial crisis, navigated the rise and eventual acquisition of its primary competitor's parent, and maintained market share dominance through continuous technology and land infrastructure investment. Businesses that survive this many evolutionary pressures develop organizational capabilities that compound over decades.
The duopoly market structure is itself a product of Darwinian selection — dozens of regional salvage auction companies have been absorbed or eliminated over the past 30 years, leaving only Copart and IAA with the scale, network effects, and land infrastructure to serve national insurance carriers. This natural selection process has created barriers to entry that are nearly impossible to replicate. A new entrant would need to simultaneously assemble a global buyer network, acquire hundreds of land parcels near major cities, build technology platforms, and establish carrier relationships — a multi-billion-dollar, multi-decade undertaking with no guarantee of success.
My primary concern is the long-tail existential risk from autonomous driving and advanced driver assistance systems. If accident frequency declines structurally by 30-50% over the next 15-20 years, Copart's total addressable market contracts proportionally. While this timeline is long, evolutionary investors must think in decades, and I cannot ignore a plausible scenario where the company's core demand driver — vehicle accidents — diminishes materially. This risk warrants a wider margin of safety than other council members require, which is why I insist on entry below $28.

Verdict & Actions

Disagreements: I push back on David Tepper and Mohnish Pabrai's willingness to buy at current prices without demanding greater compensation for tail risks. The insurance volume cycle will indeed normalize, but my concern extends beyond the current cycle to structural questions about accident frequency in an ADAS/autonomous driving future. At $33.39, the stock prices in cyclical recovery but provides minimal cushion against longer-term technological disruption. Paying $28 instead of $33 buys roughly 15% additional margin of safety — meaningful insurance against risks that are difficult to quantify but impossible to dismiss.

Actions:

Set limit orders at $28 and exercise extreme patience. Copart has traded below $28 as recently as 2022, and continued insurance volume weakness could present another entry opportunity within 12-18 months.
Commission a deep-dive analysis on ADAS adoption rates and their measurable impact on total-loss frequency. If data shows accident frequency has already begun declining due to ADAS, downgrade conviction to 5 and tighten the maximum position size to 2%.

Read Full Council Deliberation

Complete investor frameworks, growth assumptions, fair value calculations, and dissent analysis

Quantitative Quality Dashboard

COMPOSITE

74

/100

A- BUY

Composite quality score across financial strength, competitive moat, industry dynamics, and valuation attractiveness.

Financial Quality 30%

76 /100

ROIC 23.3%, Rev 5yr CAGR 16.1%

Competitive Moat 25%

98 /100

WIDE moat, WIDENING

Industry Attractiveness 20%

66 /100

TAM growth 8%, GROWTH stage, Pricing: STRONG

Valuation 25%

54 /100

-1% upside, Implied growth < history

Weighted Contribution

23

24

13

14

Financial Quality

Competitive Moat

Industry Attractiveness

Valuation

Decision Drivers Ranked by outcome impact

Rank	Driver	Impact	Source
1	Insurance Volume Cycle Recovery U.S. insurance unit volumes declined 10.7% in the most recent quarter as carriers tightened underwriting standards. CEO Liaw stated 'historical data does indicate over the long haul that these are more cyclical forces than they are secular.' This single variable determines whether Copart returns to 10-12% revenue growth or remains stuck at 5-7%. Every 1% change in insurance volume flows directly to Copart's auction counts.	High	Q2 FY2026 Earnings Call
2	Buyer Liquidity Flywheel & ASP Growth U.S. insurance average selling prices grew 9% year-over-year excluding catastrophe effects even as industry vehicle values normalized — proof the buyer network is widening its advantage. Copart generates 'record average selling prices' per CEO Liaw, meaning the marketplace premium over IAA continues expanding. This ASP growth directly increases Copart's fee-on-value revenue without requiring any volume growth.	High	Q2 FY2026 Earnings Call
3	Total-Loss Frequency Secular Tailwind Total-loss frequency has risen from 15.6% to 24.2% over the past decade — an 860 basis point increase driven by rising repair costs, vehicle complexity, and ADAS sensor replacement expense. Each percentage point increase adds roughly 400,000-500,000 vehicles annually to Copart's addressable market. The question is whether this tailwind decelerates as the rate approaches 25-30% or continues as vehicle technology complexity compounds.	High	Industry Analysis
4	Capital Allocation Awakening After years of hoarding cash while shares outstanding crept from 933M to 967M, management deployed $500M in buybacks year-to-date in FY2026. With $5.1B in cash, zero debt, and $1.23B annual FCF, Copart can repurchase 3-5% of shares annually while maintaining financial fortress status. CEO Liaw purchased 4,523 shares at $6.78 in January 2026 — a modest but symbolically important open-market buy.	Medium	Management & Governance Analysis
5	Operating Margin Trajectory Margins have compressed 570 basis points from the 42.2% COVID peak (2021) to 36.5% (2025), driven by investment in sales force expansion, technology, and international operations. The critical question is whether margins stabilize at 35-37% (reflecting normalized operating leverage) or continue declining toward 30% as management invests ahead of revenue. Historical pre-COVID margins of 30-35% suggest 36.5% may actually be above-normal, not deteriorating.	Medium	Financial Analysis

Epistemic Classification What we know vs. believe vs. assume

STRUCTURAL Verifiable Facts

Revenue: $4.65B FY2025, 12.7% 14-year CAGR
Net income: $1.55B, 15 consecutive years of growth
FCF: $1.23B, FCF/share $1.27
Zero debt ($2.7M), $5.1B cash
Operating margin: 36.5%, ROIC: 16.2% (28%+ cash-adjusted)

Confidence:

95%

PROBABILISTIC Model Estimates

Insurance volume recovery within 12-18 months (65%)
Total-loss frequency continues rising toward 28-30% over next decade (60%)
Buyback program sustains 2-3% annual share reduction (55%)
Operating margins stabilize at 35-37% range (60%)
EPS compounds at 12-15% over next 5 years (55%)

Confidence:

55%

NARRATIVE Belief-Based

Buyer liquidity flywheel is permanently self-reinforcing and cannot be replicated
International expansion will eventually replicate U.S. economics
Management's belated capital allocation pivot signals permanent behavioral change
IAA under RB Global ownership will remain a structurally inferior competitor

Confidence:

35%

Key Assumptions Tagged by durability & reversibility

Insurance volume decline is cyclical — recovery within 12-18 months as carriers reinvest in policy growth, restoring 10-12% revenue growth

Fragile Reversible

Total-loss frequency continues rising 50-80 bps annually as vehicle repair complexity increases with ADAS sensors and EV battery costs

Durable Irreversible

Buyer liquidity advantage over IAA is structural and widening — Copart's 9% ASP growth reflects a network effect that compounds with scale

Durable Reversible

Management sustains $1B+ annual buybacks, reducing share count 2-3% annually and converting dead cash into per-share compounding

Fragile Reversible

Operating margins stabilize at 35-37% as investment in sales force and technology produces proportional revenue growth within 2-3 years

Fragile Reversible

Thesis Killers Exit triggers that invalidate the thesis

Insurance Volume Structural Decline

If the 10.7% U.S. insurance unit decline reflects permanent consumer coverage loss rather than cyclical tightening, Copart's revenue growth engine downshifts from 12% to 5-7% permanently. At current valuation, the stock could reprice 20-30% lower as the market reclassifies it from compounder to mature industrial.

Trigger: U.S. insurance unit volumes decline >8% for 4+ consecutive quarters (current: -10.7% one quarter) = stock pain; decline persists 6+ quarters = thesis killer

IAA/RB Global Buyer Liquidity Convergence

If RB Global invests aggressively in IAA's technology platform and buyer network, narrowing the ASP gap, Copart's moat erodes from 'wide' to 'narrow.' Insurance contracts would become price-competitive, compressing margins and potentially triggering market share loss.

Trigger: IAA ASP gap narrows to <5% of Copart pricing for 2+ quarters (current: estimated 10%+ premium) = thesis killer

Total-Loss Frequency Reversal

If autonomous driving technology, improved ADAS, or regulatory changes reduce accident severity, total-loss frequency could plateau or reverse — eliminating the secular volume tailwind that has driven 860 bps of growth over a decade. This would cap Copart's addressable market growth at GDP-level rates.

Trigger: Total-loss frequency declines below 22% for 2+ consecutive years (current: 24.2%) = thesis killer

Capital Allocation Regression

If management abandons the nascent buyback program and reverts to cash hoarding while share count continues rising, the per-share compounding thesis collapses. The $5.1B cash pile earning 4-5% treasury yields in a business generating 28% cash-adjusted ROIC is value destruction measured in billions.

Trigger: Share count rises above 975M while cash exceeds $6B and no material buybacks for 3+ quarters (current: 967M shares, $500M YTD buybacks) = stock pain

Structural Analogies Pattern comparisons (NOT outcome predictions)

Visa/Mastercard Network Effects Model

Two-Sided Marketplace + Liquidity Flywheel

Copart's buyer liquidity flywheel operates with identical economic physics to payment networks: more buyers drive higher prices, attracting more sellers, which attract more buyers. Like Visa, Copart never owns inventory — it clips a fee on every transaction from both sides. The 9% ASP growth despite normalizing vehicle values mirrors Visa's ability to grow revenue per transaction independent of transaction count.

Key Difference

Copart's TAM is smaller and cyclically exposed to insurance underwriting, but competitive position within its market is arguably stronger than Visa's

Source

Competition Analysis

GEICO Cost Advantage Compounding

Structural Cost Advantage + Patient Capital

Just as GEICO's direct distribution model created a permanent cost advantage that compounded over decades as the insurance market grew, Copart's owned-yard model and online auction platform create structural cost and performance advantages that widen with scale. GEICO's path from niche insurer to dominant player mirrors Copart's expansion from regional salvage yard to global auction platform.

Assessment

Copart is mid-innings in the GEICO compounding arc — international expansion represents untapped runway

Source

Business Model Analysis

Moody's/S&P Duopoly Economics

Regulatory-Adjacent Duopoly + Pricing Power

The Copart/IAA duopoly mirrors the credit rating agency duopoly: two dominant players in a market where customers cannot practically self-provide the service, switching costs are high due to integration complexity, and the smaller player (IAA/Fitch) persistently trails the leader's economics. Both industries enjoy 35%+ operating margins sustained over decades.

Assessment

Copart lacks the explicit regulatory moat of rating agencies but compensates with physical infrastructure barriers

Source

Industry Analysis

Conviction Dashboard

79

Overall Conviction

95

Data Quality

90

Moat Durability

49

Valuation Confidence

High Certainty 40%

Duopoly market position (80-90% combined share), buyer liquidity network effect widening (9% ASP growth), zero-debt balance sheet with $5.1B cash, 15-year consecutive earnings growth record, fee-on-value pricing model

Medium Certainty 40%

Insurance volume recovery timing (12-18 months), total-loss frequency continuation (24.2% and rising), margin stabilization at 35-37%, buyback program sustainability, international expansion economics replicating U.S. returns

Low Certainty 20%

Long-term ADAS/autonomous driving impact on accident frequency, IAA competitive response under RB Global ownership, management behavioral change on capital allocation durability, regulatory risk to cross-border vehicle exports

DCF Valuation Scenarios

Bear Case

$28.38

-15.0% upside

25% prob · 5.0% growth · 10.0% WACC

Base Case

$32.25

-3.4% upside

50% prob · 9.0% growth · 9.0% WACC

Bull Case

$39.76

+19.1% upside

25% prob · 12.0% growth · 8.5% WACC

Valuation Range Distribution

$33

$28

Bear

$32

Base

$40

Bull

Current Price Weighted Value

Probability-Weighted Intrinsic Value

$33.16

-0.7% margin of safety at current price of $33.39

Weighted average of bear, base & bull scenario valuations — the gap between this and the current price is your margin of safety

Implied 5-Year IRR at Current Price ($33.39)

Your estimated annualized return over 5 years if you buy today and the stock reaches each scenario's fair value

Bear IRR

-3.2%

annualized

Base IRR

-0.7%

annualized

Bull IRR

3.6%

annualized

Probability-Weighted IRR: -0.3% Poor — below cost of equity

Reverse DCF — What Is the Market Pricing In?

Solving for the growth rate implied by today's stock price

Market-Implied FCF Growth

8.5%

priced into $33.39

Historical 5yr FCF CAGR

27.2%

actual track record

Market vs History

Below

favorable: market expects less than history

WACC / Terminal Growth

9.5% / 2.5%

Probability of Achieving Implied Growth

High — 8.5% implied growth is well below 27% historical, very achievable

What Must Go Right

Total-loss frequency must continue rising (high confidence per 10-year trend). Insurance volumes must eventually normalize (cyclical, not structural per management). Buybacks must continue at current or accelerated pace.

What Could Go Wrong

Prolonged insurance cycle downturn lasting 3+ years. International expansion proves unprofitable. Management reverts to cash hoarding rather than sustaining buybacks. Autonomous driving reduces accident frequency within 10 years (low probability).

Read Full Growth & Valuation Analysis

DCF scenarios, growth projections, reinvestment analysis, and fair value methodology

Industry Analysis

STRUCTURAL

Industrials

Specialty Business ServicesCopart

Every 1.3 seconds in the United States, a car is involved in a collision severe enough to generate an insurance claim. For a growing share of those claims — 24.2% as of the fourth quarter of calendar 2025, up from 15.6% just a decade earlier — the insurer declares the vehicle a total loss.

Market Cap

$32.3B

CPRT

Revenue CAGR

16.1%

5-year

ROIC

16.2%

TTM

Employees

N/A

Workforce

Industry Scorecard GROWTH STAGE

Total Addressable Market

$18B

TAM Growth Rate

8.0%

Market Concentration

HIGH

Copart and IAA (RB Global) control ~80-90% of U.S. insurance salvage market

Industry Lifecycle

GROWTH

Total-loss frequency rising secularly with vehicle complexity; international mar...

Capital Intensity

MODERATE

CapEx/Revenue ~12% predominantly for land acquisition that appreciates; minimal ...

Cyclicality

MODERATE

Unit volumes fluctuate with insurance cycles and miles driven, but total-loss fr...

Regulatory Burden

LOW

State-level title and salvage branding regulations are established and manageabl...

Disruption Risk

LOW

Physical infrastructure, network effects, and multi-year contracts create barrie...

Pricing Power

STRONG

Fee-on-value model with demonstrably superior auction returns creates economic s...

Key Industry Dynamics

The salvage vehicle auction industry processes approximately 10-12 million total-loss and damaged vehicles annually in the United States alone, generating an estimated $15-20 billion in transaction value through a platform model that connects insurance carriers with a global network of dismantlers, rebuilders, and exporters.

Regulatory Environment

Antitrust

This fringe has been slowly eroding over time as the duopoly expands yard networks and as insurance carriers consolidate their supply chains with fewer, larger partners.

Read Full Industry Analysis

Deep dive into market structure, TAM sizing, competitive dynamics, and regulatory environment

Competitive Position

PROBABILISTIC

CPRT Competitive Position

Market Share

55-60%

US Market

Competitive Threats

Threat

Cyclicality

The vulnerability, such as it exists, is cyclical rather than competitive.

DURABLE

Threat

Execution Risk

International expansion carries execution risk, as each market requires local regulatory knowledge, yard development, and buyer network cultivation that cannot be imported from the U.S.

LOW

Competitive Advantages

Copart possesses a genuine, durable economic moat anchored by the two highest-quality moat sources in Vinall's hierarchy: network effects and cost savings that flow directly to customers. The buyer liquidity advantage documented in our competitive analysis — where Copart generates 9% year-over-year ASP growth excluding catastrophe effects while industry vehicle values normalize — is not merely a competitive edge; it is a compounding economic machine that puts measurable dollars into insurance carriers' pockets through superior price discovery.

This is the "GOAT Moat" in Vinall's framework: an advantage where the company wins precisely because it makes its customers wealthier, creating a self-reinforcing cycle where customer alignment and competitive advantage are the same thing. What makes this moat particularly compelling is that it is widening through active execution, not coasting on legacy positioning.

Copart's 1,000-engineer technology team is deploying AI across damage assessment, dispatch optimization, and buyer-vehicle matching to accelerate the flywheel.

Read Full Competitive & Moat Analysis

Economic moat assessment, competitive threats, switching costs, and market position durability

How CPRT Makes Money

STRUCTURAL

Imagine you're an auto insurance company, and one of your policyholders just totaled their car. You owe the policyholder a check for the car's value — say $25,000. But you now own a wrecked vehicle sitting on the side of a highway. That wreck is still worth something — maybe $8,000 to a body shop in Texas that needs the engine, or $6,000 to an exporter who will ship it to Nigeria for rebuilding, or $10,000 to a Lithuanian dismantler who wants the transmission and airbag modules. Your problem: you have no idea who these buyers are, you have no way to get the wreck off the highway, and every day it sits there costs you storage fees and an angry policyholder waiting for their settlement. Enter Copart. Within hours of your total-loss declaration, Copart dispatches a tow truck from the largest towing network in the industry, hauls the wreck to one of its hundreds of owned storage yards across North America, photographs and catalogs the damage, obtains the title through its Title Express platform (which processes loan payoffs and title retrieval 10+ days faster than you could do it yourself), and lists the vehicle for online auction. On auction day, dozens of registered buyers worldwide — dismantlers, rebuilders, exporters, body shops — compete in real-time bidding. The vehicle sells for $10,500. Copart collects fees from you (the seller) based on a percentage of the sale price plus fixed service charges for towing, storage, and title processing. Copart also collects a buyer premium from the winning bidder. You, the insurer, receive the net proceeds, which reduce your loss cost on this claim by $10,500.

The Business Model in Simple Terms

This was examined in depth in Chapter 2, so I will state it concisely here: Copart's advantage is that it runs the biggest, most liquid auction for wrecked cars in the world, and being the biggest makes it better, which makes it bigger. A competitor with $10 billion could buy land and build yards, but they cannot buy 20 years of buyer network development. The buyers are the moat. No buyers, no high prices. No high prices, no insurance carriers. No insurance carriers, no inventory. No inventory, no buyers. The circle cannot be broken from the outside.

Global Reach

Worldwide operations across diverse markets

Subscription Model

Predictable recurring revenue with high retention

Network Effects

Two-sided marketplace dynamics are textbook and powerful

Key Financial Metrics

Margin & Returns

Operating Margin 36.5%

Net Margin 33.4%

ROIC TTM 16.2%

Cash Flow

FCF Per Share $1.27

FCF Yield 3.8%

Debt/Equity 0.01x

Read Full Business Model Analysis

Revenue quality, unit economics, pricing power, and structural advantages in the business model

Capital Allocation

DATA-DRIVEN

CapEx

40%

$3.4B total

Reinvested

50%

$4.2B total

Buybacks

4%

$0.4B total

Dividends

0%

$0.0B total

Net Debt Repaid

5%

$0.4B total

Capital Uses (Normalized to 100%)

Avg OCF: $1.2B/year

CapEx

Reinv

CapEx Reinvested Buybacks Dividends Net Debt Repaid

Share Count Evolution

Shares reduced from 919M to 967M over 7 years

--5.2%

Shares Outstanding

Capital Allocation Over Time ($B)

Historical Capital Allocation ($ in Billions)

Year	OCF	CapEx	Reinvest	Buybacks	Dividends	Net Debt	Shares (M)
2025	$1.8	$0.6	$1.2	—	—	—	967
2024	$1.5	$0.5	$0.9	—	—	-$0.0	963
2023	$1.4	$0.5	$0.8	—	—	+$0.0	957
2022	$1.2	$0.3	$0.3	—	—	-$0.4	952
2021	$1.0	$0.5	$0.5	—	—	—	948
2020	$0.9	$0.6	$0.3	—	—	—	941

OCF=Operating Cash Flow | Net Debt=Debt issued minus repaid (positive=borrowed) | Reinvested=OCF minus all uses

Debt & Acquisitions

Financing activity beyond operating cash flow

Total Acquisitions

$0.1B

Net Debt Change

-$0.4B

↓ REDUCED

Capital Allocation Quality (Buffett-Style)

68/100

CPRT shows mixed capital allocation. Strong positives include zero debt issuance, net debt reduction (-$0.4B), minimal acquisitions ($0.1B), and exceptional 24.4% FCF/share CAGR — the ultimate Buffett proof of value creation. However, 40.4% CapEx intensity is high for a Buffett-style capital-light ideal, buybacks are negligible at 4.4% while shares actually INCREASED ~5% (dilution from SBC), and ROIC has nearly halved from 28.9% to 16.2% over 7 years — a concerning deterioration that suggests reinvested capital is earning progressively lower returns. The pristine balance sheet and strong per-share economics keep this solidly average-to-good, but declining ROIC and share dilution prevent a higher score.

○ Capital-light (CapEx < 25%)

○ Active buybacks (> 25%)

○ Effective (shares -10%+)

✓ Debt reduction

Financial Performance (5-Year History)

Metric	2024	2023	2022	2021	2020
Revenue ($M)	$4,237	$3,870	$3,501	$2,693	$2,206
Operating Income ($M)	$1,572	$1,487	$1,375	$1,136	$816
Net Income ($M)	$1,362	$1,238	$1,090	$936	$700
Free Cash Flow ($M)	$962	$848	$839	$528	$314
ROIC	18.04%	21.79%	25.35%	26.74%	27.35%
EPS	$1.42	$2.59	$4.59	$3.96	$2.98
FCF Per Share	$1.00	$0.89	$0.88	$0.56	$0.35

Revenue & Net Income Trend YoY growth shown below bars

EPS & Free Cash Flow Per Share

Read Full Financial Deep Dive

10-year trends, margin analysis, cash flow quality, and balance sheet assessment

Institutional Financial Metrics

COMPUTED FROM SEC DATA

ROIC (Avg)

23.3%

±4.5% · 10yr

Incr. ROIC

-56%

3yr avg (ΔNOPAT/ΔIC)

Rev CAGR

15.5%

10-year

Net Debt/EBITDA

-1.0x

Net cash

Rule of 40

36

Below 40

Compound Annual Growth Rates

Metric

3-Year

5-Year

10-Year

Revenue

9.9%

16.1%

15.5%

EPS (Diluted)

-29.6%

-11.7%

-4.7%

Free Cash Flow

13.6%

31.4%

25.6%

Margin Trends

Gross Margin

↑ EXPANDING

45.2%

Avg 44.9% · Slope +0.32pp/yr

Operating Margin

↑ EXPANDING

36.5%

Avg 36.2% · Slope +0.76pp/yr

FCF Margin

↑ EXPANDING

26.5%

Avg 19.0% · Slope +1.28pp/yr

ROIC Consistency

23.3% ± 4.5%

Min: 16.2% Max: 28.9%

10/10 years > 15% 7/10 years > 20%

Balance Sheet Strength

Net Debt / EBITDA

-1.05x

Interest Coverage (EBIT)

6814x

Share Dilution

+27.4%/yr

784.0% total over 9 years

Reinvestment

Reinvest Rate (Avg)

35.3%

Capital Intensity

52.4%

Moderate reinvestment to sustain growth

Rule of 40

36 Below threshold

Rev Growth 9.7% + FCF Margin 26.5%

Incremental ROIC (ΔNOPAT / ΔInvested Capital) Measures return on each new dollar invested

When a company reinvests profits back into the business, how much extra profit does each new dollar generate? For example, if a company invests $100M more and earns $25M more in operating profit, its incremental ROIC is 25%. Above 20% is excellent — it means the company is getting better as it grows, not just bigger.

42%

17

12%

18

85%

19

16%

20

23%

21

24%

22

-184%

23

6%

24

9%

25

3yr Avg: -56.4% 5yr Avg: -24.5% All-Time: 3.6%

Year-by-Year Institutional Metrics

Year	Rev ($B)	NOPAT ($B)	IC ($B)	ROIC	Incr. ROIC	Gross %	Oper %	FCF %	EPS
2016	$1.3	$0.3	$1.5	18.3%	—	42.9%	32.0%	12.5%	$2.47
2017	$1.4	$0.4	$1.8	27.3%	42%	43.6%	31.9%	22.1%	$1.71
2018	$1.8	$0.4	$2.0	23.4%	12%	42.2%	32.4%	13.2%	$1.80
2019	$2.0	$0.6	$2.2	28.9%	85%	44.0%	35.1%	13.3%	$2.58
2020	$2.2	$0.7	$2.9	27.4%	16%	45.7%	37.0%	14.2%	$2.98
2021	$2.7	$0.9	$3.9	26.7%	23%	49.9%	42.2%	19.6%	$3.96
2022	$3.5	$1.1	$4.6	25.4%	24%	45.9%	39.3%	24.0%	$4.59
2023	$3.9	$1.2	$4.6	21.8%	-184%	44.9%	38.4%	21.9%	$2.59
2024	$4.2	$1.2	$5.6	18.0%	6%	45.0%	37.1%	22.7%	$1.42
2025	$4.6	$1.4	$7.2	16.2%	9%	45.2%	36.5%	26.5%	$1.60

ROIC Trend Dashed line = 15% threshold

Margin Trends

Economic Moat Assessment

Moat Grade

WIDE

Franchise business with highest-quality moat sources (GOAT M...

Trajectory

↑ WIDENING

More important than width

Total Moat Score

22/25

5 dimensions scored 0-5

Switching Costs

4/5

Multi-year insurance contracts, system integration, title-processing workflow de...

Network Effects

5/5

Two-sided marketplace where more bidders drive higher ASPs (9% ex-CAT growth) at...

Cost Advantages

4/5

Largest towing network with best route density, owned yard portfolio reducing pe...

Intangible Assets

4/5

Two decades of trust with major insurance carriers, proprietary auction transact...

Efficient Scale

5/5

Duopoly market structure where two operators absorb 80-90% of volume; third entr...

10yr Durability 9/10

Physical infrastructure + network effects + customer-aligned value creation crea...

AI Risk LOW

Physical vehicle handling cannot be disintermediated by software; AI amplifies i...

AI Impact ↑ MOAT+

Total loss decision tool expands addressable market, AI-powered matching improve...

Flywheel STRONG

Buyer liquidity → higher ASPs → more seller volume → more inventory diversity → ...

Moat Sources

Copart possesses a genuine, durable economic moat anchored by the two highest-quality moat sources in Vinall's hierarchy: network effects and cost savings that flow directly to customers. The buyer liquidity advantage documented in our competitive analysis — where Copart generates 9% year-over-year ASP growth excluding catastrophe effects while industry vehicle values normalize — is not merely a competitive edge; it is a compounding economic machine that puts measurable dollars into insurance carriers' pockets through superior price discovery.<br><br>This is the "GOAT Moat" in Vinall's framework: an advantage where the company wins precisely because it makes its customers wealthier, creating a self-reinforcing cycle where customer alignment and competitive advantage are the same thing. What makes this moat particularly compelling is that it is widening through active execution, not coasting on legacy positioning.<br><br>Copart's 1,000-engineer technology team is deploying AI across damage assessment, dispatch optimization, and buyer-vehicle matching to accelerate the flywheel.

Moat Threats

In Chapter 1, we established that the salvage vehicle auction industry operates as a near-perfect duopoly with 80-90% of U.S. insurance salvage volume concentrated between two operators. What makes Copart's position within this duopoly remarkable is not merely its larger share — it is the widening gap between its economic output and its competitor's.

Moat Durability Rating:

Wide & Widening — Strong durable moat

Rare Compounder Test

Verdict: HIGH

Rare Compounding Potential: High Copart exhibits the strongest structural compounding characteristics of any industrial services business in public ma...

Why It Might Compound

Stable returns on invested capital over the past decade
Strong free cash flow generation supports dividends and buybacks
Disciplined capital return via buybacks
ROIC of 16.2% indicates value creation above capital cost

Why It Might Not

Moat showing signs of erosion under competitive pressure
Competitive pressure increasing from new entrants
Core growth trajectory slowing
Technology disruption poses long-term risk
Elevated debt levels limit flexibility

Psychological Conviction Test

✓ Survives 50% drawdown

✓ Survives 5-year underperformance

✓ Survives public skepticism

Read Full Rare Compounder Assessment

Structural compounding characteristics, reinvestment capacity, and duration analysis

Critical Review: Holes in This Analysis

SKEPTIC'S VIEW

Source: Automated skeptical analysis. These are specific critiques of potential blind spots, data contradictions, and overconfidence.

No Earnings Call Transcript Available

This analysis lacks direct transcript data — all management quotes and quarterly metrics are inferred from analysis sections rather than verified against primary source material. Key claims about '9% ASP growth excluding CAT' and 'U.S. units down 10.7%' cannot be independently confirmed against specific quarterly filings.

Cash-Adjusted ROIC Masks Real Capital Allocation Failure

The analysis frames declining ROIC (28.9% to 16.2%) as a 'mathematical artifact' of cash accumulation, but this is precisely the problem: management chose to let $5.1B earn 4-5% treasury yields instead of buying back stock at 3-4% FCF yields in a business they know earns 28% on operating capital. The denominator effect IS the failure, not an excuse for it.

Margin Compression Trend Insufficiently Challenged

A 570 basis point operating margin decline over four years (42.2% to 36.5%) deserves deeper scrutiny than 'normalization from COVID peaks.' The concurrent investment in sales force, technology, and international operations without demonstrated revenue acceleration could indicate the business has reached a scale where incremental growth requires disproportionate incremental spend.

Read Full Contrarian Analysis

Devil's advocate case, blind spots, and evidence-based challenges to the bull thesis

Management & Governance Risk

GOVERNANCE

Copart's management story is defined by an unusual tension: operationally excellent execution over fifteen consecutive years of earnings growth, paired with a capital allocation record that Chapter 7 correctly identified as the company's single most significant governance weakness.

EXECUTIVE SUMMARY

Copart's management story is defined by an unusual tension: operationally excellent execution over fifteen consecutive years of earnings growth, paired with a capital allocation record that Chapter 7 correctly identified as the company's single most significant governance weakness. The leadership team — CEO Jeff Liaw, CFO Leah Stearns, Executive Chairman Jay Adair, and founder Willis Johnson as Chairman — has delivered a financial record that virtually no industrial services company can match: revenue compounding from $872 million to $4.65 billion (12.7% CAGR over fourteen years), operating margins expanding from 30% to 36.5%, and net income growing every single year from $166 million (2011) to $1.55 billion (2025) [ROIC.AI KNOWN]. On the operational dimension, this is an A+ management team that has executed the buyer liquidity flywheel described in Chapter 2 with remarkable consistency.

The capital allocation dimension tells a more complicated story. Between fiscal 2020 and fiscal 2025, the company generated approximately $4.7 billion in cumulative free cash flow [ROIC.AI] and deployed exactly $808 million in total buybacks across the entire decade (FY2016: $443M, FY2019: $365M) while shares outstanding drifted from 915 million to 967 million [ROIC.AI] — a net dilution of 5.7% during a period of extraordinary cash generation. The $5.1 billion cash pile as of Q2 FY2026 represents approximately 16% of market capitalization sitting in treasury instruments earning 4-5% in a business that generates 28% cash-adjusted ROIC on operating assets (per Chapter 5). Management's belated initiation of buybacks ($500M year-to-date in FY2026) corrects the worst of this passivity, but the opportunity cost of not buying shares at $15-20 (split-adjusted) during the 2020 pandemic trough — when the stock briefly offered a 5%+ FCF yield in a business management understood better than anyone — is permanently lost value that no amount of future buyback activity can recapture.

The insider transaction data from SEC Form 4 filings reveals one genuinely positive signal amid the noise: CEO Liaw purchased 4,523 shares at $6.78 on January 16, 2026 [SEC Form 4 KNOWN]. While modest in absolute terms ($30,666), CEO open-market purchases are relatively rare in corporate America and signal alignment between management rhetoric and personal conviction. Executive Chairman Adair's January 2026 "sell" of 7,761 shares at $0.00 appears to be a tax-related disposition (estate planning, gift, or charitable donation) rather than a market-based sale, consistent with typical Form 4 filings for long-tenured executives with large legacy positions.

The board structure warrants attention: twelve directors standing for annual election is an unusually large board, and Willis Johnson (founder) retains the Chairman role despite an operational transition to his son-in-law Jay Adair and subsequently to Jeff Liaw. The lead independent director is Daniel Englander, whose role and tenure deserve scrutiny as the key governance check on a company with deep founder family influence.

PILLAR 1: MANAGEMENT CREDIBILITY

Copart's management earns credibility through an unusual mechanism: they do not provide explicit financial guidance. CEO Liaw does not issue quarterly revenue or EPS targets, which means there is no formal guidance-versus-actual scorecard to evaluate. This is a deliberate choice — as Liaw stated on the February 2026 call: "I don't tend to read too much into any given quarter or any given quarter's percentage change versus a year ago." The absence of guidance eliminates the temptation to manage expectations and the risk of overpromising, which is philosophically consistent with a long-term orientation.

However, management does make implicit promises through strategic commentary, and these can be tracked. On the Q2 FY2026 call, Liaw characterized the insurance volume decline as "cyclical" with historical precedent, stating that "historical data does indicate over the long haul that these are more cyclical forces than they are secular." This is a testable claim. If insurance volumes have not recovered within 12-18 months, Liaw's framing will have been either wrong or premature — and the market will punish the stock accordingly.

The more telling credibility test is the AI narrative. Liaw devoted a substantial portion of his prepared remarks to artificial intelligence, describing "exponential monthly increases" in AI usage, naming specific applications (business analytics, document processing, call-for-release, driver dispatch, total loss decision tool), and noting his own "significant personal engagement in Quad code." This level of specificity is unusual and suggests genuine engagement rather than buzzword deployment. However, the AI commentary is disconnected from any quantified financial impact — no metrics on cost savings, no productivity benchmarks, no revenue attributed to the total loss decision tool. When management invests significant call time in a narrative without financial proof points, it often signals that the story is more advanced than the results.

Management Credibility Score: CREDIBLE — No guidance means no misses, which is the most honest approach for a cyclical-adjacent business. Operational track record (15 years of earnings growth) demonstrates execution consistency that speaks louder than any guidance framework. The AI narrative is a mild concern — enthusiasm without quantification is a pattern worth monitoring.

PILLAR 2: LEADERSHIP STABILITY & KEY PERSON RISK

Leadership Lineage:
Copart's leadership succession is a family dynasty story that has — against the odds — produced excellent outcomes:
- Willis Johnson (Founder, Chairman of the Board): Founded Copart in 1982, built it from a single salvage yard to a public company, and remains Chairman at approximately 76 years of age. His stock option grant of 17,813 shares in December 2025 [SEC Form 4 KNOWN] confirms active board engagement.
- A. Jayson Adair (Executive Chairman): Johnson's son-in-law, who served as CEO from 2010 to approximately 2022-2023 before transitioning to Executive Chairman. Adair oversaw the critical 2011-2022 period when revenue grew from $872M to $3.5B and operating margins expanded from 30% to 39%. His January 2026 "sell" of 7,761 shares at $0.00 [SEC Form 4 KNOWN] is consistent with estate planning or charitable gifting, not a bearish signal.
- Jeff Liaw (CEO): Became CEO circa 2022-2023, having joined from a management consulting and legal background (Harvard Law). Liaw represents a generational transition from founder-operator to professional manager — a shift that has succeeded at companies like Costco (Sinegal to Jelinek to Vachris) and failed at others. The early evidence is positive: fifteen consecutive quarters of earnings growth under his tenure ($0.26 to $0.41 quarterly EPS from Q1 FY2023 to Q4 FY2025) [ROIC.AI quarterly EPS KNOWN].
- Leah Stearns (CFO): Joined from a financial services background. Her tenure appears to coincide with the capital allocation pivot — the buyback initiation in FY2026 and the articulated capital return framework suggest she may be the catalyst for the more shareholder-friendly approach.

Key Person Risk Assessment: MODERATE

The founder dynasty introduces both strength and risk. Johnson and Adair's continued involvement provides institutional memory and cultural continuity. But the transition from founder-operators to professional management is inherently fragile — if Liaw departs, the pipeline of qualified successors for a business this specialized is thin. The 1,000-person engineering team cited repeatedly on calls suggests depth of operational talent, but the CEO role at a company with such deep insurance carrier relationships and founder family dynamics requires a specific temperament that limits the candidate pool.

The board composition — twelve directors — is large by modern governance standards. Director stock option grants of 17,813 shares each (December 2025) [SEC Form 4 KNOWN] to Johnson, Englander, Fisher, Meeks, LeBon, Sparks, and Blunt suggest a standardized compensation package that aligns director interests with shareholder returns. The board includes a lead independent director (Daniel Englander), which provides a governance check on the Johnson/Adair family influence.

PILLAR 3: CAPITAL ALLOCATION TRACK RECORD

This is where the governance analysis gets uncomfortable, and Chapter 7's "capital allocation indictment" must be extended with quantitative precision.

The Cash Hoarding Record:

FY	FCF Generated ($M)	Buybacks ($M)	% of FCF Returned	Cash on B/S ($M)	Source
2016	$159	$443	279%*	N/A	[ROIC.AI]
2017	$320	$0	0%	N/A	[ROIC.AI]
2018	$247	$0	0%	N/A	[ROIC.AI]
2019	$273	$365	134%*	N/A	[ROIC.AI]
2020	$326	$0	0%	N/A	[ROIC.AI]
2021	$528	$0	0%	N/A	[ROIC.AI]
2022	$839	$0	0%	N/A	[ROIC.AI]
2023	$848	$5	0.6%	$1,407	[ROIC.AI / BS]
2024	$962	$7	0.7%	$1,908	[ROIC.AI / BS]
2025	$1,231	$0	0%	$2,009	[ROIC.AI / BS]

*FY2016 and FY2019 buybacks exceeded annual FCF, funded partially from prior year cash balances.

From FY2020 through FY2025 — a six-year period during which the company generated $3,934M in cumulative FCF — total buyback activity was approximately $12 million ($5M + $7M in negligible cashless exercise offsets). Management returned 0.3% of cash generated during the most prolific earnings period in the company's history. This is not conservative capital allocation; it is capital allocation paralysis.

Acquisition Track Record: DISCIPLINED

The counterweight to the buyback criticism is Copart's remarkably disciplined acquisition history. Total acquisition spending over ten years was approximately $325 million [ROIC.AI: sum of acquisitions 2016-2025], with no single deal exceeding $164M (FY2017) and most years showing less than $10M. There are no goodwill impairments visible in the data, no massive write-downs, and no evidence of empire-building through M&A. The Purple Wave acquisition ($109M in FY2022) is producing 17% gross transaction value growth — a clear success. This discipline is rare and valuable; many companies with Copart's cash generation would have made at least one value-destructive mega-acquisition during this period.

CapEx Record: STRATEGIC BUT HEAVY

CapEx grew from $173M (FY2016) to $569M (FY2025), a 3.3x increase [ROIC.AI: derived from OCF - FCF]. As a percentage of revenue, capex has risen from approximately 13.6% (2016) to 12.2% (2025), which is actually slightly improved despite the absolute dollar increase. CFO Stearns' statement that the land portfolio is now in an "incredibly strong position" relative to a decade ago suggests the heaviest investment phase may be maturing, which would improve FCF conversion going forward.

Capital Allocation Score: 3/5 — Disciplined acquirer (A+), strategic land investor (A), but catastrophically passive on capital return (D) for six consecutive years. The FY2026 buyback initiation ($500M year-to-date) brings the score up from what would have been a 2/5 just one year ago.

PILLAR 4: REGULATORY & LEGAL EXPOSURE

The regulatory environment is benign. Copart operates in a state-regulated industry (salvage title regulations, environmental requirements for yard operations) that creates modest barriers to entry but does not expose the company to the kind of existential regulatory risk that faces pharmaceutical, financial, or technology companies. The 10-K risk factors disclose standard operational risks — dependence on limited major vehicle sellers, international expansion risks, weather event exposure — but no pending material litigation is highlighted beyond a generic reference to Note 15 commitments and contingencies.

The January 26, 2026 8-K filing — "Entry into Material Agreement, Creation of Direct Financial Obligation" — is notable and warrants investigation. This is not a standard earnings or voting 8-K; it indicates a new material financial obligation was created less than a month before the Q2 earnings call. Given Copart's historical near-zero debt position ($2.7M in FY2025), this could signal a credit facility establishment (perhaps to fund accelerated buybacks), a lease obligation, or another material commitment. Without the specific filing content, this is a monitoring item rather than a red flag.

Regulatory Risk: LOW — No material litigation, no regulatory enforcement actions, standardized state-level compliance requirements that are well-established and navigable.

PILLAR 5: GOVERNANCE STRUCTURE & ALIGNMENT

Ownership Alignment:
The Johnson/Adair family's continued involvement as Chairman and Executive Chairman respectively suggests substantial insider ownership, though the exact percentage is not quantified in the provided data. CEO Liaw's open-market purchase of 4,523 shares at $6.78 in January 2026 [SEC Form 4 KNOWN] — while modest ($30,666) — is directionally positive. In an industry where most CEOs never make open-market purchases, any buy signal is meaningful.

Board Independence:
The twelve-member board with a lead independent director (Englander) and majority voting standard in uncontested elections reflects governance practices that meet institutional standards. The uniform director stock option grants (17,813 shares each in December 2025) create alignment without excessive dilution. The board skills matrix referenced in the proxy statement suggests the Nominating Committee applies formal criteria, though the Johnson family's influence on director selection is an inherent concern in any founder-influenced company.

Compensation Framework:
Detailed compensation data is not available in the provided context beyond the proxy statement structure references. However, stock-based compensation of $38 million in FY2025 on $4.65 billion in revenue represents 0.8% of sales — among the lowest SBC-to-revenue ratios in any public company. This signals either genuinely modest compensation practices or a compensation structure weighted toward cash rather than equity (which would be less ideal from an alignment perspective). Given the founder family's presumed large ownership, modest SBC is consistent with insiders who don't need equity grants to be aligned.

PILLAR 6: EARNINGS CALL BEHAVIORAL ANALYSIS

The February 2026 transcript reveals a management team that is confident, measured, and occasionally evasive in revealing ways.

Positive Signals:
- Liaw's willingness to lead with bad news (insurance unit declines) before presenting offsets (ASP growth) demonstrates intellectual honesty. Many CEOs bury negative trends in the middle of prepared remarks.
- CFO Stearns' transparency on the one-time $6.8M international VAT accrual and the detailed segment-level disclosures (including adjusted-for-CAT metrics) reflect a desire to provide investors with clean underlying performance data.
- The absence of promotional language around financial targets — no "we're confident in achieving double-digit growth" or "we expect to outperform" — is refreshingly restrained.

Concerning Signals:
- When analyst Bob Labick asked directly about returns from the sales force buildup, Liaw's response was artfully non-specific: "I don't tend to read too much into any given quarter" and "there's more to the picture than just that alone." This is a non-answer to a reasonable question about ROI on a specific investment. A more forthcoming CEO would say: "We've won X accounts, improved retention by Y basis points, and expect the investment to be margin-accretive by FY2027."
- The AI section of prepared remarks consumed approximately 15-20% of CEO commentary time but included zero quantified impact metrics. "Exponential monthly increases in use" describes adoption, not value creation. A more disciplined framework would include: cost savings quantified, cycle time improvements measured, or revenue attributed to the total loss decision tool.
- Liaw's reference to his own "significant personal engagement in Quad code" is unusual for a CEO of a $32B company — it signals either genuine technical fluency or an attempt to associate himself with the AI narrative for credibility purposes.

MANAGEMENT GOVERNANCE SCORECARD

---MANAGEMENT GOVERNANCE SCORECARD---
CREDIBILITY: 4 | Fifteen consecutive years of earnings growth with no formal guidance (honest approach); AI commentary lacks financial proof points
LEADERSHIP_STABILITY: 4 | Successful founder-to-professional-manager transition; Johnson/Adair/Liaw continuity provides institutional memory; moderate key person risk on CEO
CAPITAL_ALLOCATION: 3 | Exceptionally disciplined acquirer (zero impairments); catastrophically passive on buybacks 2020-2025 (0.3% of FCF returned); FY2026 buyback initiation improves trajectory
REGULATORY_RISK: LOW | No material litigation, no enforcement actions, benign state-level regulatory environment
GOVERNANCE_QUALITY: 4 | Lead independent director, majority voting, annual elections for all 12 directors; low SBC dilution (0.8% of revenue); founder family influence is a monitoring item
CONTROVERSY_RISK: LOW | No ESG controversies, no political exposure, environmentally positive business model (vehicle recycling)
OVERALL_MANAGEMENT: GOOD | Operationally excellent management team with a meaningful but correctable capital allocation weakness; the FY2026 buyback pivot is the key test of whether management has genuinely evolved
---END SCORECARD---

BUFFETT/MUNGER VERDICT

Buffett famously requires intelligence, energy, and integrity — and warns that without the third, the first two are dangerous. Copart's management passes all three tests, though the integrity dimension requires nuance.

Intelligence: Demonstrated. The 2003 online migration that created the buyer liquidity moat, the Title Express platform, the AI deployments, and the disciplined land acquisition strategy all reflect a management team that thinks strategically over multi-decade horizons. Liaw's analytical approach (Harvard Law, consulting background) complements the founder family's operational instincts.

Energy: Demonstrated. Revenue grew from $872M to $4.65B over fourteen years, operating in eleven countries, with a 1,000-person engineering team building technology that outpaces a well-capitalized competitor (IAA/RB Global). This is not a coasting management team.

Integrity: Mostly demonstrated, with one notable caveat. The fifteen-year record of transparent financial reporting, no restatements, minimal SBC dilution, and honest earnings call commentary all support integrity. CEO Liaw's open-market purchase — putting personal money behind his words — is a positive signal. The caveat is the capital allocation passivity: sitting on $5 billion in cash while shareholders' per-share returns were diluted by creeping share count growth is not dishonest, but it represents a failure of fiduciary imagination that a Buffett or Munger would have corrected within one to two years, not six.

Verdict: Management ENHANCES the investment case, with a condition. The operational track record is exceptional by any measure, and the moat described in Chapter 2 is a direct product of management execution over two decades. The capital allocation weakness is real but is being actively corrected — the $500M in FY2026 buybacks represents a genuine pivot, and the January 2026 8-K (material financial obligation) may signal further capital return infrastructure. If buybacks sustain at $1B+ annually, the capital allocation score improves from 3/5 to 4/5, and management quality shifts from "Good" to "Excellent." The investment case should be evaluated on the assumption that the buyback program continues — but monitored quarterly for any retreat to the cash-hoarding posture.

With management quality assessed — operationally excellent, capital-allocation-improving, honest if imperfect — the complete mosaic of business quality, financial performance, competitive position, growth trajectory, contrarian risks, and leadership credibility is now assembled. The final question is synthesis: at $33.39, does the totality of evidence justify putting capital at risk, and under what conditions does this become a compelling investment?

Read Full Management & Governance Review

Leadership assessment, capital allocation track record, compensation, and succession planning

Earnings Call Q&A Investment Summary

GPT5 ANALYSIS

Source: GPT5 deep analysis of earnings call Q&A. Extracts analyst concerns, guidance details, competitive dynamics, and investment implications.

Key Takeaways

Insurance volume headwind is real but management frames it as cyclical, not structural: U.S. insurance units declined 10.7% (4.8% excluding catastrophe comparisons), driven by consumer coverage pullbacks — Liaw characterized this as consistent with historical insurance industry cyclicality, stating "historical data does indicate over the long haul that these are more cyclical forces than they are secular," but provided no specific timeline for recovery. - ASP growth is offsetting volume declines, demonstrating genuine pricing power: U.S. insurance ASPs grew 9% excluding catastrophe effects,...

Executive Summary

Insurance volume headwind is real but management frames it as cyclical, not structural: U.S. insurance units declined 10.7% (4.8% excluding catastrophe comparisons), driven by consumer coverage pullbacks — Liaw characterized this as consistent with historical insurance industry cyclicality, stating "historical data does indicate over the long haul that these are more cyclical forces than they are secular," but provided no specific timeline for recovery.
ASP growth is offsetting volume declines, demonstrating genuine pricing power: U.S. insurance ASPs grew 9% excluding catastrophe effects, generating record average selling prices even as industry-wide vehicle values normalized — this is the strongest evidence that the buyer liquidity flywheel described in earlier chapters is functioning independently of market conditions.
Capital return program has launched but scale remains modest relative to $5.1B cash position: Management repurchased over 13 million shares for $500M fiscal year-to-date, the company's first meaningful buyback activity in seven years — a welcome pivot but representing only 1.5% of market capitalization against a $5.1B cash pile and zero debt.
AI deployment is substantive but unquantified: CEO Liaw devoted approximately 15-20% of prepared remarks to artificial intelligence initiatives across damage assessment, document processing, dispatch, and the total loss decision tool launched two years ago — specific applications were named but zero financial impact metrics were provided.
Land investment cycle appears to be maturing, which has positive FCF implications: CFO Stearns confirmed the company is in "an incredibly strong position" on land capacity after investing "several hundreds of millions of dollars per year" over the past decade, and CEO Liaw referenced the 2016 "20/20/20" initiative as context — suggesting the heaviest capex phase may be subsiding, which would improve free cash flow conversion.

Detailed Q&A Analysis

Guidance & Outlook

Copart does not provide explicit financial guidance — no quarterly or annual revenue, EPS, or margin targets are offered. This is consistent with the company's long-standing policy and reflects CEO Liaw's stated philosophy of avoiding short-term metric management. Instead, management anchors its forward-looking commentary to operational drivers: total-loss frequency trends, insurance carrier policy dynamics, ASP performance, and capacity investment plans.

The most concrete forward-looking data point from the call was the total-loss frequency update: 24.2% in Q4 calendar 2025, up 10 basis points from a year ago despite the prior year including hurricane effects. Liaw emphasized the multiyear trajectory — from 15.6% in 2015 to 23.1% in 2025 — calling the trend "inexorable." This word choice is notable: it signals management's high conviction that the secular tailwind remains intact regardless of the current cyclical volume downturn.

On the insurance cycle specifically, Liaw offered a nuanced but non-committal view. He acknowledged that carriers have "now far healthier income statements, but also compromised growth" from the rate increases they've passed through. His expectation is that "some or many will begin reinvesting in growth and driving policy growth in the form of both marketing dollars as well as more competitive approaches to rates." The hedge language — "some or many" — reveals appropriate uncertainty about timing while maintaining confidence in the eventual direction.

Key Analyst Questions & Management Responses

Q (Bob Labick, CJS Securities): What macro factors are you watching to indicate when industry volumes return to growth, excluding total-loss frequency?

A (Jeff Liaw): Liaw pointed to the auto insurance industry's own cyclicality — premium growth and contraction, combined ratios — and noted that carriers are now in a healthy profitability position after years of lagging rate increases. He expects carriers will eventually "reinvest in growth" through competitive pricing and marketing. He also highlighted that consumer financial pain has been more pronounced recently than at any point during his tenure, leading to coverage reductions.

Investment Implication: Management sees volume recovery as dependent on two external factors: (1) insurance carriers shifting from profitability defense to growth investment, and (2) consumer financial health improving enough to restore coverage levels. Neither factor is within Copart's control, and neither has a specific timeline. Investors should model 2-4 more quarters of volume pressure as the base case. The positive takeaway is that Liaw was frank about the severity of consumer financial stress rather than dismissing it.

Q (Bob Labick, CJS Securities): SG&A has returned to operating leverage after a period of growth. What have you learned from the sales force buildup? What are the returns on that investment?

A (Jeff Liaw): Liaw broadened the question beyond sales force alone, citing investments in "commercial capabilities," product and technology (including Title Express and AI tools). He stated these investments drive "differential returns to us, both in the form of unit volume, better selling prices, better economics period overall." However, he explicitly declined to provide specific ROI metrics, saying "I don't tend to read too much into any given quarter or any given quarter's percentage change versus a year ago."

Investment Implication: This was the most evasive answer on the call. An analyst directly asked for evidence of returns on a multi-year investment, and the CEO responded with qualitative assertions rather than quantitative proof. The statement "every investment we make is justified by the economics of this specific project itself" is a process description, not an outcome description. Investors should note that management has not yet demonstrated measurable returns from the SG&A investment cycle in public disclosures. This does not mean the investments are failing — it may reflect legitimate difficulty in attribution — but it leaves the "investment mode to harvest mode" transition thesis from Chapter 6 unverified.

Q (Craig Kennison, Baird): How do you frame your need to invest in additional land capacity over the next 1, 5, and 10 years, considering faster cycle times and market share dynamics?

A (Leah Stearns / Jeff Liaw): CFO Stearns confirmed an "incredibly strong position" on land capacity today, the result of "several hundreds of millions of dollars per year" in disciplined investment over the past decade. She noted that faster cycle times allow more efficient land use but that additional investments "may" be required for the 10-year horizon. CEO Liaw referenced the 2016 "20/20/20" initiative (20 new facilities, 20 expansions, 20 months) as historical context for the company's land investment approach.

Investment Implication: This is the single most positive exchange on the call for FCF-focused investors. The CFO's characterization of land capacity as "incredibly strong" — combined with the qualifier that future needs are forward-looking and contingent — suggests the heaviest phase of the land investment cycle is maturing. If capex normalizes from $569M (FY2025) toward $400-450M while revenue continues growing, FCF conversion will improve meaningfully. The reference to the decade-old 20/20/20 initiative also signals that management thinks in multi-year capacity horizons, not quarter-to-quarter, which is aligned with long-term shareholder interests.

Competitive Landscape Discussion

Competition was not directly discussed in the Q&A — no analyst asked about IAA/RB Global, market share dynamics, or competitive pressure. This absence is itself informative: in a quarter with 10.7% unit volume declines, the fact that not a single analyst raised competitive concerns suggests the investment community views the duopoly structure as stable and the volume decline as industry-wide rather than Copart-specific.

In his prepared remarks, Liaw made several implicit competitive statements. The reference to "recent account wins for which we have empirical before and after returns data" suggests Copart is actively gaining share from IAA during the downturn — consistent with the competitive dynamics analyzed in Chapter 2 where Copart's superior buyer liquidity becomes more pronounced when volumes are scarce. The characterization of Copart's tow network as "the largest in the industry by a long shot" and Title Express as "5x or more the largest such platform in our industry" are assertive competitive claims that went unchallenged.

Capital Allocation & Financial Strategy

The capital return discussion was brief but significant. CFO Stearns reported $5.1 billion in cash and $6.4 billion in total liquidity with zero debt, and disclosed that the company has "repurchased over 13 million shares for an aggregate amount of over $500 million" fiscal year-to-date. The buyback was described as beginning with open-market purchases followed by a 10b5-1 plan — a systematic approach suggesting this is the beginning of an ongoing program rather than a one-time action.

Notably, neither Liaw nor Stearns quantified a target buyback pace, annual authorization, or framework for how they will determine the appropriate scale of capital return. The January 26, 2026 8-K filing ("Entry into Material Agreement, Creation of Direct Financial Obligation") was not discussed on the call, which is unusual — this could represent a credit facility establishment, which would provide additional buyback flexibility without consuming cash reserves.

Risks & Concerns Raised

The primary risk acknowledged was the insurance volume headwind, which management framed as cyclical with historical support. Liaw's acknowledgment that "consumers have felt the pain more in the past year or so, relatively speaking" is the most honest assessment of demand risk from any Copart call in the available transcript. The $6.8 million international VAT accrual mentioned by Stearns is a one-time item but signals expanding complexity in international tax compliance as the company scales globally.

Growth Catalysts & Opportunities

Key catalysts identified from the call include: (1) Purple Wave's 17% gross transaction value growth "significantly outperforming the broader industry," confirming the adjacent-market expansion thesis; (2) international noninsurance unit growth of 9.1%, the fastest-growing subsegment; (3) fleet and bank/finance seller volume growing at "healthy double-digit pace" in the U.S.; and (4) dealer services unit growth of 5%. These noninsurance channels collectively demonstrate that Copart's growth story extends beyond the cyclically soft insurance volume base.

Investment Thesis Impact

Factor	Bull Case Impact	Bear Case Impact
9% ASP growth ex-CAT	Proves buyer liquidity flywheel works independently of market	ASP growth may plateau as vehicle values fully normalize
10.7% insurance unit decline	Creates attractive entry point during cyclical trough; volume recovery will accelerate revenue	May prove stickier than "cyclical" framing suggests if consumer coverage loss is structural
$500M buyback initiation	Signals capital allocation pivot; at $1B+/year creates 2-3% EPS accretion	$500M is modest against $5.1B cash; pace may not accelerate
Land capacity "incredibly strong"	Capex normalization ahead improves FCF; infrastructure moat already built	"May require additional investments" leaves capex uncertainty
AI deployment without quantification	Future productivity gains not yet priced in by market	Spending without measurable returns could be a sunk cost
Purple Wave 17% GTV growth	Proves platform model extends to adjacent asset classes	Still early-stage; may not be material for years

Key Metrics to Monitor

U.S. insurance unit volume trajectory — track quarterly to assess whether "cyclical" framing holds; recovery by Q1-Q2 FY2027 would validate thesis
Insurance ASP growth rate ex-CAT — the 9% figure is the strongest evidence of moat; deceleration below 5% would signal buyer liquidity plateau
Buyback pace and cash deployment — monitor whether $500M H1 pace sustains or accelerates in H2 FY2026 and into FY2027
Capex as % of revenue — normalization below 11% would signal the land investment cycle has matured
International operating margin — convergence from 23.6% toward 30%+ would confirm international growth is value-creative
Total-loss frequency — annual updates (next meaningful data point: mid-2026) to assess whether the 10 bps annual increase pace is decelerating

Management Tone Assessment

CEO Liaw's tone was confident but appropriately measured — he led with the negative volume data, acknowledged consumer financial stress more directly than in prior periods, and avoided promotional language about near-term financial outcomes. The AI commentary was the one area where enthusiasm outpaced evidence. CFO Stearns was crisp and disciplined — her segment-level disclosures included both reported and adjusted-for-CAT figures, the international VAT accrual was flagged proactively, and the buyback disclosure was specific ($500M, 13M+ shares) rather than vague. The overall management tone conveyed a team that is comfortable navigating a cyclical downturn and confident in the long-term secular thesis, without overselling the near-term outlook. This is the tone profile of experienced operators, not promotional storytellers.

Read Full Earnings Q&A Analysis

Management signals, analyst concerns, guidance details, and investment implications from the call

Investment Thesis Summary

EXECUTIVE SUMMARY

PILLAR 1: MANAGEMENT CREDIBILITY

PILLAR 2: LEADERSHIP STABILITY & KEY PERSON RISK

PILLAR 3: CAPITAL ALLOCATION TRACK RECORD

PILLAR 4: REGULATORY & LEGAL EXPOSURE

PILLAR 5: GOVERNANCE STRUCTURE & ALIGNMENT

PILLAR 6: EARNINGS CALL BEHAVIORAL ANALYSIS

MANAGEMENT GOVERNANCE SCORECARD

BUFFETT/MUNGER VERDICT

Executive Summary

Detailed Q&A Analysis

Guidance & Outlook

Key Analyst Questions & Management Responses

Competitive Landscape Discussion

Capital Allocation & Financial Strategy

Risks & Concerns Raised

Growth Catalysts & Opportunities

Investment Thesis Impact

Key Metrics to Monitor

Management Tone Assessment